Information between 25th February 2026 - 17th March 2026
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
| Division Votes |
|---|
|
4 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted No - in line with the party majority and against the House One of 135 Conservative No votes vs 3 Conservative Aye votes Tally: Ayes - 213 Noes - 145 |
|
4 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and against the House One of 105 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 129 Noes - 132 |
|
2 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 113 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 144 Noes - 143 |
|
2 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 139 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 202 Noes - 155 |
|
2 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 113 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 142 Noes - 140 |
|
2 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 113 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 143 Noes - 140 |
|
2 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 110 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 144 Noes - 140 |
|
2 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 136 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 192 Noes - 155 |
|
10 Mar 2026 - Victims and Courts Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 148 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 216 Noes - 170 |
|
10 Mar 2026 - Victims and Courts Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 160 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 252 Noes - 171 |
|
10 Mar 2026 - Victims and Courts Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 165 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 257 Noes - 174 |
|
10 Mar 2026 - Victims and Courts Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 172 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 273 Noes - 180 |
|
9 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 162 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 200 Noes - 162 |
|
11 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 149 Conservative Aye votes vs 1 Conservative No votes Tally: Ayes - 163 Noes - 153 |
|
11 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 181 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 215 Noes - 180 |
|
11 Mar 2026 - Crime and Policing Bill - View Vote Context Lord Booth voted Aye - in line with the party majority and in line with the House One of 178 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 227 Noes - 221 |
| Written Answers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Blood Cancer: Immunotherapy
Asked by: Lord Booth (Conservative - Life peer) Wednesday 11th March 2026 Question to the Department of Health and Social Care: To ask His Majesty's Government how many patients per annum are expected to be treated by the NHS with Car-T cell therapy for Non-Hodgkin Lymphoma. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) The following table shows the number of patients treated per annum with CAR-T cell therapy for non-Hodgkin lymphoma, from 2023 to 2025, and in total:
|
| Select Committee Documents |
|---|
|
Tuesday 10th March 2026
Oral Evidence - Dr Robert Goldstone, and Professor Ewan Birney Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee Found: and AI Tuesday 10 March 2026 11.50 am Watch the meeting Members present: Lord Mair (The Chair); Lord Booth |
|
Tuesday 10th March 2026
Oral Evidence - Professor Sir Mark Caulfield Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee Found: and AI Tuesday 10 March 2026 10.15 am Watch the meeting Members present: Lord Mair (The Chair); Lord Booth |
|
Tuesday 3rd March 2026
Oral Evidence - Department for Science, Innovation and Technology, Department for Science, Innovation and Technology, and Department for Science, Innovation and Technology Science and Technology Committee Found: Tuesday 3 March 2026 2 pm Watch the meeting Members present: Lord Mair (The Chair); Lord Berkeley; Lord Booth |
| Calendar |
|---|
|
Tuesday 10th March 2026 10 a.m. Science and Technology Committee - Oral evidence Subject: Innovation in the NHS: personalised medicine and AI At 10:15am: Oral evidence Professor Sir Mark Caulfield At 11:15am: Oral evidence Dr Robert Goldstone Professor Ewan Birney View calendar - Add to calendar |
|
Tuesday 17th March 2026 10 a.m. Science and Technology Committee - Oral evidence Subject: Innovation in the NHS: personalised medicine and AI At 10:15am: Oral evidence Professor Florian Markowetz At 11:15am: Oral evidence Rich Scott - CEO at Genomics England View calendar - Add to calendar |
|
Tuesday 24th March 2026 10 a.m. Science and Technology Committee - Oral evidence Subject: Innovation in the NHS: personalised medicine and AI At 10:15am: Oral evidence Matthew Durdy - CEO at Cell and Gene Therapy Catapult Chris Molloy - CEO at Medicines Discovery Catapult At 11:15am: Oral evidence Professor Anneke Lucassen View calendar - Add to calendar |
| Select Committee Inquiry |
|---|
|
3 Mar 2026
Innovation in the NHS: Personalised Medicine and AI Science and Technology Committee (Select) Not accepting submissions No description available |